InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-16.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Velleca Mark A., Director. Officer active across 2 companies, notably G1 Therapeutics, Inc.. Aggregated, 24 filings have been logged. History available since 11 May 2021. The latest transaction was filed on 30 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations24 total
75,000 shares0Common StockSEC:0001415889-25-002494:0
5,208 shares@ US$3.6018.7% of flowCommon StockSEC:0001415889-23-013339:0
57,286 shares@ US$0.3915.2% of flowCommon StockSEC:0001562180-23-006271:0
8,929 shares@ US$2.1018.2% of flowCommon StockSEC:0001415889-23-009959:0
11,228 shares@ US$1.6718.8% of flowCommon StockSEC:0001415889-23-005218:0
8,424 shares@ US$1.5012.6% of flowCommon StockSEC:0001415889-22-012797:0
15,000 shares@ US$0.394.4% of flowCommon StockSEC:0001562180-22-007293:0
20,000 shares@ US$0.395.8% of flowCommon StockSEC:0001562180-22-006791:0
4,294 shares@ US$2.6212.0% of flowCommon StockSEC:0001415889-22-009773:0
80,000 shares@ US$0.3922.9% of flowCommon StockSEC:0001562180-22-006214:0
5,542 shares@ US$2.030.0077% mcap57.5% of flowCommon StockSEC:0001415889-22-006741:0
2,897 shares@ US$3.020.0057% mcap42.5% of flowCommon StockSEC:0001415889-22-003185:0
15,000 shares@ US$0.397.4% of flowCommon StockSEC:0001562180-22-001223:0
15,000 shares@ US$0.3914.7% of flowCommon StockSEC:0001562180-22-001223
40,000 shares@ US$0.3919.4% of flowCommon StockSEC:0001562180-21-006964:0
40,000 shares@ US$0.3938.8% of flowCommon StockSEC:0001562180-21-006964
10,000 shares@ US$0.392.5% of flowCommon StockSEC:0001562180-21-004949
10,000 shares@ US$0.394.8% of flowCommon StockSEC:0001562180-21-004949:0
10,000 shares@ US$0.392.4% of flowCommon StockSEC:0001562180-21-004348
10,000 shares@ US$0.394.6% of flowCommon StockSEC:0001562180-21-004348:0
20,000 shares@ US$0.399.2% of flowCommon StockSEC:0001562180-21-003737:0
20,000 shares@ US$0.399.2% of flowCommon StockSEC:0001562180-21-003737
10,000 shares@ US$0.394.6% of flowCommon StockSEC:0001562180-21-003460
10,000 shares@ US$0.394.6% of flowCommon StockSEC:0001562180-21-003460:0
24 of 24 declarations
About Velleca Mark A.
Mark A. Velleca is a director at G1 Therapeutics, Inc. and Black Diamond Therapeutics, Inc. In this role, he participates in the strategy and governance of these companies. With notable experience in the biopharmaceutical sector, Mark A. Velleca brings important skills to the board. His commitment to innovation and sustainability is essential for G1 Therapeutics and Black Diamond Therapeutics.
